US Patent 12134767 Materials and methods for treatment of hemoglobinopathies
Patent 12134767 was granted and assigned to Vertex Pharmaceuticals on November, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 6 Nov, 2024
Golden AI
Edits made to:
Infobox (+15 properties)
Article (+355 characters)
US Patent 12134767 Materials and methods for treatment of hemoglobinopathies
Article
Patent abstract
The present application provides materials and methods for treating hemoglobinopathies. More specifically, the application provides methods for producing progenitor cells that are genetically modified via genome editing to increase the production of fetal hemoglobin (HbF), as well as modified progenitor cells (including, for example, CD34
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Matthew Hebden Porteus0
Date of Patent
November 5, 2024
0Patent Application Number
169092830
Date Filed
June 23, 2020
0Patent Citations
Patent Primary Examiner
CPC Code
Find more entities like US Patent 12134767 Materials and methods for treatment of hemoglobinopathies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
